US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals Sept 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Allstate, Autozone and Vertex Pharmaceuticals, on Wednesday.
HIGHLIGHTS
* Allstate Corp ALL.N: TD Cowen raises target price to $260 from $231 |
* Autozone Inc AZO.N: D.A. Davidson cuts target price to $3,500 from $3,750 |
* Martin Marietta Materials, Inc. MLM.N: Jefferies cuts target price to $670 from $720 |
* Vertex Pharmaceuticals Inc VRTX.O: Jefferies raises target price to $640 from $633 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $320 from $345 |
Following is a summary of research actions on US companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Acadia Healthcare Company Inc ACHC.O: Leerink Partners raises PT to $33 from $30 |
* Allstate Corp ALL.N: TD Cowen raises target price to $260 from $231 |
* Ally Financial Inc ALLY.N: Truist Securities cuts target price to $50 from $51 |
* American Express Company AXP.N: Truist Securities cuts target price to $370 from $375 |
* Amgen Inc AMGN.O: Jefferies raises target price to $410 from $367 |
* Amneal Pharma AMRX.O: Oppenheimer initiates with outperform rating; price target $27 |
* Amrize AMRZ.N: Deutsche Bank cuts target price to $56 from $64 |
* Anaptysbio Inc ANAB.O: Leerink Partners cuts target price to $81 from $90 |
* Anixa Biosciences Inc ANIX.O: H.C. Wainwright cuts target price to $6 from $7 |
* Applied Digital Corp APLD.O: UBS initiates coverage with buy rating and target $38 |
* Ardent Health Inc ARDT.N: BMO initiates with market perform rating; target price $11 |
* Autozone Inc AZO.N: BMO cuts target price to $3,500 from $,4000 |
* Autozone Inc AZO.N: D.A. Davidson cuts target price to $3,500 from $3,750 |
* Autozone Inc AZO.N: Exane BNP Paribas cuts target price to $3,561 from $3,979 |
* Autozone Inc AZO.N: Roth MKM cuts target price to $3,850 from $4,023 |
* Autozone Inc AZO.N: TD Cowen cuts target price to $3,400 from $3,500 |
* Autozone Inc AZO.N: Truist Securities cuts target price to $3,648 from $3,817 |
* Bank7 Corp BSVN.O: KBW raises target price to $62 from $56 |
* Belden Inc BDC.N: Needham initiates coverage with buy rating; price target $140 |
* Carnival Corp CCL.N: Jefferies cuts target price to $33 from $35 |
* CBIZ Inc CBZ.N: William Blair cuts to market perform rating |
* Celldex Therapeutics Inc. CLDX.O: Leerink Partners raises target price to $88 from $70 |
* Cipher Digital Inc CIFR.O: UBS initiates coverage with buy rating and target price $23 |
* Citizens Financial CFG.N: Truist Securities cuts target price to $77 from $80 |
* Collegium Pharmaceutical COLL.O: Oppenheimer initiates with outperform rating; PT $50 |
* Community Health Systems CYH.N: BMO initiates coverage with market perform rating; PT $3 |
* Compass Therapeutics Inc CMPX.O: Guggenheim cuts target price to $4 from $8 |
* Compass Therapeutics Inc CMPX.O: Jefferies cuts target price to $3 from $8 |
* Compass Therapeutics Inc CMPX.O: Wedbush cuts target price to $1 from $5 |
* Compass Therapeutics Inc CMPX.O: Wedbush cuts to neutral from outperform |
* Constellation Brands Inc STZ.N: UBS cuts target price to $145 from $168 |
* Core Scientific Inc CORZ.O: UBS initiates coverage with buy rating and target price $24 |
* Coreweave Inc CRWV.O: UBS initiates coverage with buy rating and target price $120 |
* Cormedix Inc CRMD.O: Oppenheimer initiates with outperform rating; price target $15 |
* Cummins CMI.N: JP Morgan cuts target price to $600 from $690 |
* Dauch Corp DCH.N: Jefferies cuts to hold from buy; cuts target price to $7.10 from $8.25 |
* Fifth Third Bancorp FITB.N: Truist Securities cuts target price to $63 from $64 |
* Fox Corp FOXA.O: Moffettnathanson raises target price by $5 to $70 |
* GE Aerospace GE.N: Jefferies cuts target price to $435 from $455 |
* General Dynamics Corp GD.N: Bernstein cuts target price to $407 from $421 |
* Graphic Packaging Holding Company GPK.N: JP Morgan cuts target price to $11.50 from $12.50 |
* Graphic Packaging Holding Company GPK.N: JP Morgan raises to overweight from neutral |
* Guardian Pharmacy Services Inc GRDN.N: Keybanc initiates with overweight rating; PT $52 |
* HCA Healthcare, Inc. HCA.N: BMO initiates coverage with outperform rating; PT $495 |
* HII HII.N: Bernstein cuts target price to $327 from $341 |
* Huntington Bancshares Inc HBAN.O: Truist Securities cuts target price to $19 from $20 |
* Hut 8 Corp HUT.O: UBS initiates coverage with buy rating and target price $143 |
* Innoviva Inc INVA.O: Oppenheimer assumes coverage with outperform rating; target $35 |
* KB Home KBH.N: Barclays cuts target price to $49 from $57 |
* KB Home KBH.N: RBC cuts target price to $50 from $53 |
* KB Home KBH.N: Truist Securities cuts target price to $50 from $55 |
* Keycorp KEY.N: Truist Securities cuts target price to $23 from $24 |
* L3Harris Technologies, Inc. LHX.N: Bernstein cuts target price to $346 from $365 |
* M&T Bank Corporation MTB.N: Truist Securities cuts target price to $250 from $268 |
* Martin Marietta Materials, Inc. MLM.N: Jefferies cuts target price to $670 from $720 |
* Marvell Technology MRVL.O: Seaport Research Partners initiates with buy rating; PT $270 |
* Merck & Co Inc MRK.N: TD Cowen raises target price to $155 from $137 |
* Nektar Therapeutics NKTR.O: Wedbush cuts target price to $50 from $80 |
* Nike Inc NKE.N: Oppenheimer cuts target price to $52 from $60 |
* Northrop Grumman NOC.N: Bernstein cuts target price to $620 from $653 |
* Onsemi ON.O: Seaport Research Partners initiates coverage with buy rating; PT $100 |
* Pacira Biosciences Inc PCRX.O: Oppenheimer initiates with outperform rating; PT $32 |
* PG&E Corp PCG.N: UBS cuts target price to $14 from $19 |
* PG&E Corp PCG.N: UBS cuts to neutral from buy |
* Philip Morris International Inc PM.N: UBS raises target price to $193 from $182 |
* Regions Financial RF.N: Truist Securities cuts target price to $31 from $34 |
* Roku Inc ROKU.O: Moffettnathanson raises target price by $7 to $160 |
* RTX Corporation RTX.N: Bernstein cuts target price to $223 from $232 |
* Semtech Corp SMTC.O: Seaport Research Partners initiates with buy rating; target $200 |
* SiTime Corp SITM.O: Seaport Research Partners initiates coverage with neutral rating |
* Tenet Healthcare Corp THC.N: BMO initiates with market perform rating; target price $265 |
* Terawulf Inc WULF.O: UBS initiates coverage with buy rating and target price $24 |
* The Baldwin Insurance Group BWIN.O: Raymond James cuts to underperform from strong buy |
* The Toro Company TTC.N: Oppenheimer initiates coverage with outperform rating; PT $120 |
* Thor Industries Inc THO.N: Jefferies cuts target price to $82 from $90 |
* UiPath Inc PATH.N: RBC cuts target price to $15 from $17 |
* UiPath Inc PATH.N: Truist Securities cuts target price to $14 from $17 |
* UiPath Inc PATH.N: UBS cuts target price to $15 from $19 |
* Vanda Pharmaceuticals VNDA.O: Oppenheimer initiates with outperform rating; PT $10 |
* Vertex Pharmaceuticals Inc VRTX.O: Jefferies raises target price to $640 from $633 |
* Viatris Inc VTRS.O: Oppenheimer initiates with outperform rating; price target $25 |
* Viking Therapeutics Inc VKTX.O: Oppenheimer raises target price to $120 from $100 |
* Viking Therapeutics Inc VKTX.O: Truist Securities raises target price to $87 from $83 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $320 from $345 |
* Weatherford International Plc WFRD.O: UBS cuts target price to $116 from $120 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Dauch
See all newsDauch Corporation - Dauch Announces CFO Succession and Realignment
US STOCKS ON THE MOVE-Microsoft, Salesforce, Bristol Myers
US STOCKS ON THE MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers
Brief: Dauch Corporation Announces Financial Leadership Succession Plan And Executive Realignment
US STOCKS ON THE MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences